2024-07-08 04:00:08 ET
Summary
- Inovio is on track for filing its BLA for INO-3107 in the latter half of 2024.
- INO-3107 has little in the way of pipeline support.
- Expect significant dilution as Inovio proceeds with its BLA and anticipated approval and launch of INO-3107.
This is my ninth Inovio ( INO ) article, following 02/2024's "Inovio: Planning A BLA To Reverse Its Long Path Of Misfortunes" ("Planning"). In Planning, I rated Inovio a "Hold" when it was trading at $4.90; I missed Inovio's huge jump; as I write on 07/05/2024 it trades at $8.89....
Read the full article on Seeking Alpha
For further details see:
Inovio Pharmaceuticals: Upcoming BLA Is Critical